TY - JOUR AU - Vincent, J. L. AU - Taccone, F. AU - Schmit, X. PY - 2007 DA - 2007// TI - Classification, incidence, and outcomes of sepsis and multiple organ failure JO - Contrib Nephrol VL - 156 UR - https://doi.org/10.1159/000102071 DO - 10.1159/000102071 ID - Vincent2007 ER - TY - JOUR AU - Kollef, M. H. AU - Sherman, G. AU - Ward, S. AU - Fraser, V. J. PY - 1999 DA - 1999// TI - Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients JO - Chest VL - 115 UR - https://doi.org/10.1378/chest.115.2.462 DO - 10.1378/chest.115.2.462 ID - Kollef1999 ER - TY - JOUR AU - Zaragoza, R. AU - Artero, A. AU - Camarena, J. J. AU - Sancho, S. AU - Gonzalez, R. AU - Nogueira, J. M. PY - 2003 DA - 2003// TI - The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit JO - Clin Microbiol Infect VL - 9 UR - https://doi.org/10.1046/j.1469-0691.2003.00656.x DO - 10.1046/j.1469-0691.2003.00656.x ID - Zaragoza2003 ER - TY - JOUR AU - Roberts, J. A. AU - Roberts, M. S. AU - Robertson, T. A. AU - Dalley, A. J. AU - Lipman, J. PY - 2009 DA - 2009// TI - Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration? JO - Crit Care Med VL - 37 UR - https://doi.org/10.1097/CCM.0b013e3181968e44 DO - 10.1097/CCM.0b013e3181968e44 ID - Roberts2009 ER - TY - JOUR AU - Dellinger, R. P. AU - Levy, M. M. AU - Carlet, J. M. AU - Bion, J. AU - Parker, M. M. AU - Jaeschke, R. AU - Reinhart, K. AU - Angus, D. C. AU - Brun-Buisson, C. AU - Beale, R. AU - Calandra, T. AU - Dhainaut, J. F. AU - Gerlach, H. AU - Harvey, M. AU - Marini, J. J. AU - Marshall, J. AU - Ranieri, M. AU - Ramsay, G. AU - Sevransky, J. AU - Thompson, B. T. AU - Townsend, S. AU - Vender, J. S. AU - Zimmerman, J. L. AU - Vincent, J. L. PY - 2008 DA - 2008// TI - Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008 JO - Crit Care Med VL - 36 UR - https://doi.org/10.1097/01.CCM.0000298158.12101.41 DO - 10.1097/01.CCM.0000298158.12101.41 ID - Dellinger2008 ER - TY - JOUR AU - Pinder, M. AU - Bellomo, R. AU - Lipman, J. PY - 2002 DA - 2002// TI - Pharmacological principles of antibiotic prescription in the critically ill JO - Anaesth Intensive Care VL - 30 ID - Pinder2002 ER - TY - JOUR AU - Tam, V. H. AU - McKinnon, P. S. AU - Akins, R. L. AU - Rybak, M. J. AU - Drusano, G. L. PY - 2002 DA - 2002// TI - Pharmacodynamics of cefepime in patients with Gram-negative infections JO - J Antimicrob Chemother VL - 50 UR - https://doi.org/10.1093/jac/dkf130 DO - 10.1093/jac/dkf130 ID - Tam2002 ER - TY - JOUR AU - Thalhammer, F. AU - Traunmuller, F. AU - el, M. I. AU - Frass, M. AU - Hollenstein, U. M. AU - Locker, G. J. AU - Stoiser, B. AU - Staudinger, T. AU - Thalhammer-Scherrer, R. AU - Burgmann, H. PY - 1999 DA - 1999// TI - Continuous infusion versus intermittent administration of meropenem in critically ill patients JO - J Antimicrob Chemother VL - 43 UR - https://doi.org/10.1093/jac/43.4.523 DO - 10.1093/jac/43.4.523 ID - Thalhammer1999 ER - TY - JOUR AU - Nicolau, D. P. AU - Onyeji, C. O. AU - Zhong, M. AU - Tessier, P. R. AU - Banevicius, M. A. AU - Nightingale, C. H. PY - 2000 DA - 2000// TI - Pharmacodynamic assessment of cefprozil against Streptococcus pneumoniae: implications for breakpoint determinations JO - Antimicrob Agents Chemother VL - 44 UR - https://doi.org/10.1128/AAC.44.5.1291-1295.2000 DO - 10.1128/AAC.44.5.1291-1295.2000 ID - Nicolau2000 ER - TY - JOUR AU - McKinnon, P. S. AU - Paladino, J. A. AU - Schentag, J. J. PY - 2008 DA - 2008// TI - Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T > MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections JO - Int J Antimicrob Agents VL - 31 UR - https://doi.org/10.1016/j.ijantimicag.2007.12.009 DO - 10.1016/j.ijantimicag.2007.12.009 ID - McKinnon2008 ER - TY - JOUR AU - Lipman, J. AU - Gomersall, C. D. AU - Gin, T. AU - Joynt, G. M. AU - Young, R. J. PY - 1999 DA - 1999// TI - Continuous infusion ceftazidime in intensive care: a randomized controlled trial JO - J Antimicrob Chemother VL - 43 UR - https://doi.org/10.1093/jac/43.2.309 DO - 10.1093/jac/43.2.309 ID - Lipman1999 ER - TY - JOUR AU - Lipman, J. AU - Wallis, S. C. AU - Rickard, C. PY - 1999 DA - 1999// TI - Low plasma cefepime levels in critically ill septic patients: pharmacokinetic modeling indicates improved troughs with revised dosing JO - Antimicrob Agents Chemother VL - 43 ID - Lipman1999 ER - TY - JOUR AU - Roberts, J. A. AU - Lipman, J. PY - 2009 DA - 2009// TI - Pharmacokinetic issues for antibiotics in the critically ill patient JO - Crit Care Med VL - 37 UR - https://doi.org/10.1097/CCM.0b013e3181961bff DO - 10.1097/CCM.0b013e3181961bff ID - Roberts2009 ER - TY - JOUR AU - Pea, F. AU - Viale, P. AU - Furlanut, M. PY - 2005 DA - 2005// TI - Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability JO - Clin Pharmacokinet VL - 44 UR - https://doi.org/10.2165/00003088-200544100-00002 DO - 10.2165/00003088-200544100-00002 ID - Pea2005 ER - TY - JOUR AU - Ambrose, P. G. AU - Owens, R. C. AU - Garvey, M. J. AU - Jones, R. N. PY - 2002 DA - 2002// TI - Pharmacodynamic considerations in the treatment of moderate to severe pseudomonal infections with cefepime JO - J Antimicrob Chemother VL - 49 UR - https://doi.org/10.1093/jac/49.3.445 DO - 10.1093/jac/49.3.445 ID - Ambrose2002 ER - TY - JOUR AU - Benko, A. S. AU - Cappelletty, D. M. AU - Kruse, J. A. AU - Rybak, M. J. PY - 1996 DA - 1996// TI - Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections JO - Antimicrob Agents Chemother VL - 40 ID - Benko1996 ER - TY - JOUR AU - Jaruratanasirikul, S. AU - Sriwiriyajan, S. AU - Punyo, J. PY - 2005 DA - 2005// TI - Comparison of the pharmacodynamics of meropenem in patients with ventilator-associated pneumonia following administration by 3-hour infusion or bolus injection JO - Antimicrob Agents Chemother VL - 49 UR - https://doi.org/10.1128/AAC.49.4.1337-1339.2005 DO - 10.1128/AAC.49.4.1337-1339.2005 ID - Jaruratanasirikul2005 ER - TY - JOUR AU - Levy, M. M. AU - Fink, M. P. AU - Marshall, J. C. AU - Abraham, E. AU - Angus, D. AU - Cook, D. AU - Cohen, J. AU - Opal, S. M. AU - Vincent, J. L. AU - Ramsay, G. PY - 2003 DA - 2003// TI - 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference JO - Crit Care Med VL - 31 UR - https://doi.org/10.1097/01.CCM.0000050454.01978.3B DO - 10.1097/01.CCM.0000050454.01978.3B ID - Levy2003 ER - TY - JOUR AU - Knaus, W. A. AU - Draper, E. A. AU - Wagner, D. P. AU - Zimmerman, J. E. PY - 1985 DA - 1985// TI - APACHE II: a severity of disease classification system JO - Crit Care Med VL - 13 UR - https://doi.org/10.1097/00003246-198510000-00009 DO - 10.1097/00003246-198510000-00009 ID - Knaus1985 ER - TY - JOUR AU - Vincent, J. L. AU - Moreno, R. AU - Takala, J. AU - Willatts, S. AU - De Mendonca, A. AU - Bruining, H. AU - Reinhart, C. K. AU - Suter, P. M. AU - Thijs, L. G. PY - 1996 DA - 1996// TI - The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine JO - Intensive Care Med VL - 22 UR - https://doi.org/10.1007/BF01709751 DO - 10.1007/BF01709751 ID - Vincent1996 ER - TY - JOUR AU - Cockcroft, D. W. AU - Gault, M. H. PY - 1976 DA - 1976// TI - Prediction of creatinine clearance from serum creatinine JO - Nephron VL - 16 UR - https://doi.org/10.1159/000180580 DO - 10.1159/000180580 ID - Cockcroft1976 ER - TY - JOUR AU - Buck, C. AU - Bertram, N. AU - Ackermann, T. AU - Sauerbruch, T. AU - Derendorf, H. AU - Paar, W. D. PY - 2005 DA - 2005// TI - Pharmacokinetics of piperacillin-tazobactam: intermittent dosing versus continuous infusion JO - Int J Antimicrob Agents VL - 25 UR - https://doi.org/10.1016/j.ijantimicag.2004.08.012 DO - 10.1016/j.ijantimicag.2004.08.012 ID - Buck2005 ER - TY - JOUR AU - Delattre, I. K. AU - Musuamba, F. T. AU - Verbeeck, R. K. AU - Dugernier, T. AU - Spapen, H. AU - Laterre, P. F. AU - Wittebole, X. AU - Cumps, J. AU - Taccone, F. S. AU - Vincent, J. L. AU - Jacobs, F. AU - Wallemacq, P. E. PY - 2010 DA - 2010// TI - Empirical models for dosage optimization of four beta-lactams in critically ill septic patients based on therapeutic drug monitoring of amikacin JO - Clin Biochem VL - 43 UR - https://doi.org/10.1016/j.clinbiochem.2009.12.007 DO - 10.1016/j.clinbiochem.2009.12.007 ID - Delattre2010 ER - TY - JOUR AU - Drusano, G. L. PY - 2004 DA - 2004// TI - Antimicrobial pharmacodynamics: critical interactions of 'bug and drug' JO - Nat Rev Microbiol VL - 2 UR - https://doi.org/10.1038/nrmicro862 DO - 10.1038/nrmicro862 ID - Drusano2004 ER - TY - JOUR AU - Shorr, A. F. PY - 2009 DA - 2009// TI - Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit JO - Crit Care Med VL - 37 UR - https://doi.org/10.1097/CCM.0b013e31819ced02 DO - 10.1097/CCM.0b013e31819ced02 ID - Shorr2009 ER - TY - STD TI - Clinical breakpoints - bacteria[http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Disk_test_documents/EUCAST_breakpoints_v1.0_20091221.pdf] UR - http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Disk_test_documents/EUCAST_breakpoints_v1.0_20091221.pdf ID - ref26 ER - TY - JOUR AU - Falagas, M. E. AU - Kopterides, P. PY - 2007 DA - 2007// TI - Old antibiotics for infections in critically ill patients JO - Curr Opin Crit Care VL - 13 UR - https://doi.org/10.1097/MCC.0b013e32827851d7 DO - 10.1097/MCC.0b013e32827851d7 ID - Falagas2007 ER - TY - JOUR AU - Andes, D. AU - Craig, W. A. PY - 1998 DA - 1998// TI - In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae: application to breakpoint determinations JO - Antimicrob Agents Chemother VL - 42 ID - Andes1998 ER - TY - JOUR AU - Mouton, J. W. AU - Punt, N. PY - 2001 DA - 2001// TI - Use of the t > MIC to choose between different dosing regimens of beta-lactam antibiotics JO - J Antimicrob Chemother VL - 47 UR - https://doi.org/10.1093/jac/47.4.500 DO - 10.1093/jac/47.4.500 ID - Mouton2001 ER - TY - JOUR AU - Turnidge, J. D. PY - 1998 DA - 1998// TI - The pharmacodynamics of beta-lactams JO - Clin Infect Dis VL - 27 UR - https://doi.org/10.1086/514622 DO - 10.1086/514622 ID - Turnidge1998 ER - TY - JOUR AU - Williamson, R. AU - Tomasz, A. PY - 1985 DA - 1985// TI - Inhibition of cell wall synthesis and acylation of the penicillin binding proteins during prolonged exposure of growing Streptococcus pneumoniae to benzylpenicillin JO - Eur J Biochem VL - 151 UR - https://doi.org/10.1111/j.1432-1033.1985.tb09126.x DO - 10.1111/j.1432-1033.1985.tb09126.x ID - Williamson1985 ER - TY - JOUR AU - Craig, W. A. AU - Redington, J. AU - Ebert, S. C. PY - 1991 DA - 1991// TI - Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections JO - J Antimicrob Chemother VL - 27 UR - https://doi.org/10.1093/jac/27.suppl_C.29 DO - 10.1093/jac/27.suppl_C.29 ID - Craig1991 ER - TY - JOUR AU - Angus, B. J. AU - Smith, M. D. AU - Suputtamongkol, Y. AU - Mattie, H. AU - Walsh, A. L. AU - Wuthiekanun, V. AU - Chaowagul, W. AU - White, N. J. PY - 2000 DA - 2000// TI - Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis JO - Br J Clin Pharmacol VL - 50 UR - https://doi.org/10.1111/j.1365-2125.2000.00179.x DO - 10.1111/j.1365-2125.2000.00179.x ID - Angus2000 ER - TY - JOUR AU - Ikawa, K. AU - Morikawa, N. AU - Hayato, S. AU - Ikeda, K. AU - Ohge, H. AU - Sueda, T. PY - 2007 DA - 2007// TI - Pharmacokinetic and pharmacodynamic profiling of cefepime in plasma and peritoneal fluid of abdominal surgery patients JO - Int J Antimicrob Agents VL - 30 UR - https://doi.org/10.1016/j.ijantimicag.2007.04.012 DO - 10.1016/j.ijantimicag.2007.04.012 ID - Ikawa2007 ER - TY - JOUR AU - Young, R. J. AU - Lipman, J. AU - Gin, T. AU - Gomersall, C. D. AU - Joynt, G. M. AU - Oh, T. E. PY - 1997 DA - 1997// TI - Intermittent bolus dosing of ceftazidime in critically ill patients JO - J Antimicrob Chemother VL - 40 UR - https://doi.org/10.1093/jac/40.2.269 DO - 10.1093/jac/40.2.269 ID - Young1997 ER - TY - JOUR AU - Roberts, J. A. AU - Kirkpatrick, C. M. AU - Roberts, M. S. AU - Dalley, A. J. AU - Lipman, J. PY - 2010 DA - 2010// TI - First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis JO - Int J Antimicrob Agents VL - 35 UR - https://doi.org/10.1016/j.ijantimicag.2009.10.008 DO - 10.1016/j.ijantimicag.2009.10.008 ID - Roberts2010 ER - TY - JOUR AU - Boselli, E. AU - Breilh, D. AU - Cannesson, M. AU - Xuereb, F. AU - Rimmele, T. AU - Chassard, D. AU - Saux, M. C. AU - Allaouchiche, B. PY - 2004 DA - 2004// TI - Steady-state plasma and intrapulmonary concentrations of piperacillin/tazobactam 4 g/0.5 g administered to critically ill patients with severe nosocomial pneumonia JO - Intensive Care Med VL - 30 UR - https://doi.org/10.1007/s00134-004-2222-8 DO - 10.1007/s00134-004-2222-8 ID - Boselli2004 ER - TY - JOUR AU - Kitzes-Cohen, R. AU - Farin, D. AU - Piva, G. AU - Myttenaere-Bursztein, S. A. PY - 2002 DA - 2002// TI - Pharmacokinetics and pharmacodynamics of meropenem in critically ill patients JO - Int J Antimicrob Agents VL - 19 UR - https://doi.org/10.1016/S0924-8579(01)00474-5 DO - 10.1016/S0924-8579(01)00474-5 ID - Kitzes-Cohen2002 ER - TY - JOUR AU - de Stoppelaar, F. AU - Stolk, L. AU - van Tiel, F. AU - Beysens, A. AU - van der, G. S. AU - de Leeuw, P. PY - 2000 DA - 2000// TI - Meropenem pharmacokinetics and pharmacodynamics in patients with ventilator-associated pneumonia JO - J Antimicrob Chemother VL - 46 UR - https://doi.org/10.1093/jac/46.1.150 DO - 10.1093/jac/46.1.150 ID - de Stoppelaar2000 ER - TY - JOUR AU - Bhat, S. V. AU - Peleg, A. Y. AU - Lodise, T. P. AU - Shutt, K. A. AU - Capitano, B. AU - Potoski, B. A. AU - Paterson, D. L. PY - 2007 DA - 2007// TI - Failure of current cefepime breakpoints to predict clinical outcomes of bacteremia caused by gram-negative organisms JO - Antimicrob Agents Chemother VL - 51 UR - https://doi.org/10.1128/AAC.01487-06 DO - 10.1128/AAC.01487-06 ID - Bhat2007 ER - TY - JOUR AU - Tam, V. H. AU - Gamez, E. A. AU - Weston, J. S. AU - Gerard, L. N. AU - Larocco, M. T. AU - Caeiro, J. P. AU - Gentry, L. O. AU - Garey, K. W. PY - 2008 DA - 2008// TI - Outcomes of bacteremia due to Pseudomonas aeruginosa with reduced susceptibility to piperacillin-tazobactam: implications on the appropriateness of the resistance breakpoint JO - Clin Infect Dis VL - 46 UR - https://doi.org/10.1086/528712 DO - 10.1086/528712 ID - Tam2008 ER - TY - JOUR AU - Vincent, J. L. AU - Sakr, Y. AU - Sprung, C. L. AU - Ranieri, V. M. AU - Reinhart, K. AU - Gerlach, H. AU - Moreno, R. AU - Carlet, J. AU - Le Gall, J. R. AU - Payen, D. PY - 2006 DA - 2006// TI - Sepsis in European intensive care units: results of the SOAP study JO - Crit Care Med VL - 34 UR - https://doi.org/10.1097/01.CCM.0000194725.48928.3A DO - 10.1097/01.CCM.0000194725.48928.3A ID - Vincent2006 ER - TY - JOUR AU - Sun, H. K. AU - Kuti, J. L. AU - Nicolau, D. P. PY - 2005 DA - 2005// TI - Pharmacodynamics of antimicrobials for the empirical treatment of nosocomial pneumonia: a report from the OPTAMA Program JO - Crit Care Med VL - 33 UR - https://doi.org/10.1097/01.CCM.0000181528.88571.9B DO - 10.1097/01.CCM.0000181528.88571.9B ID - Sun2005 ER - TY - JOUR AU - Maglio, D. AU - Kuti, J. L. AU - Nicolau, D. P. PY - 2005 DA - 2005// TI - Simulation of antibiotic pharmacodynamic exposure for the empiric treatment of nosocomial bloodstream infections: a report from the OPTAMA program JO - Clin Ther VL - 27 UR - https://doi.org/10.1016/j.clinthera.2005.07.004 DO - 10.1016/j.clinthera.2005.07.004 ID - Maglio2005 ER - TY - JOUR AU - Scaglione, F. AU - Paraboni, L. PY - 2008 DA - 2008// TI - Pharmacokinetics/pharmacodynamics of antibacterials in the Intensive Care Unit: setting appropriate dosing regimens JO - Int J Antimicrob Agents VL - 32 UR - https://doi.org/10.1016/j.ijantimicag.2008.03.015 DO - 10.1016/j.ijantimicag.2008.03.015 ID - Scaglione2008 ER - TY - JOUR AU - Zeitlinger, M. A. AU - Erovic, B. M. AU - Sauermann, R. AU - Georgopoulos, A. AU - Muller, M. AU - Joukhadar, C. PY - 2005 DA - 2005// TI - Plasma concentrations might lead to overestimation of target site activity of piperacillin in patients with sepsis JO - J Antimicrob Chemother VL - 56 UR - https://doi.org/10.1093/jac/dki284 DO - 10.1093/jac/dki284 ID - Zeitlinger2005 ER - TY - JOUR AU - Klekner, A. AU - Bagyi, K. AU - Bognar, L. AU - Gaspar, A. AU - Andrasi, M. AU - Szabo, J. PY - 2006 DA - 2006// TI - Effectiveness of cephalosporins in the sputum of patients with nosocomial bronchopneumonia JO - J Clin Microbiol VL - 44 UR - https://doi.org/10.1128/JCM.00893-06 DO - 10.1128/JCM.00893-06 ID - Klekner2006 ER - TY - JOUR AU - Wise, R. AU - Logan, M. AU - Cooper, M. AU - Ashby, J. P. AU - Andrews, J. M. PY - 1990 DA - 1990// TI - Meropenem pharmacokinetics and penetration into an inflammatory exudate JO - Antimicrob Agents Chemother VL - 34 UR - https://doi.org/10.1128/AAC.34.8.1515 DO - 10.1128/AAC.34.8.1515 ID - Wise1990 ER - TY - JOUR AU - Lodise, T. P. AU - Lomaestro, B. AU - Drusano, G. L. PY - 2007 DA - 2007// TI - Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy JO - Clin Infect Dis VL - 44 UR - https://doi.org/10.1086/510590 DO - 10.1086/510590 ID - Lodise2007 ER - TY - JOUR AU - Lorente, L. AU - Jimenez, A. AU - Palmero, S. AU - Jimenez, J. J. AU - Iribarren, J. L. AU - Santana, M. AU - Martin, M. M. AU - Mora, M. L. PY - 2007 DA - 2007// TI - Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review JO - Clin Ther VL - 29 UR - https://doi.org/10.1016/j.clinthera.2007.11.003 DO - 10.1016/j.clinthera.2007.11.003 ID - Lorente2007 ER - TY - JOUR AU - Thompson, M. I. AU - Russo, M. E. AU - Matsen, J. M. AU - Atkin-Thor, E. PY - 1981 DA - 1981// TI - Piperacillin pharmacokinetics in subjects with chronic renal failure JO - Antimicrob Agents Chemother VL - 19 UR - https://doi.org/10.1128/AAC.19.3.450 DO - 10.1128/AAC.19.3.450 ID - Thompson1981 ER - TY - JOUR AU - Triginer, C. AU - Izquierdo, I. AU - Fernandez, R. AU - Rello, J. AU - Torrent, J. AU - Benito, S. AU - Net, A. PY - 1990 DA - 1990// TI - Gentamicin volume of distribution in critically ill septic patients JO - Intensive Care Med VL - 16 UR - https://doi.org/10.1007/BF01706354 DO - 10.1007/BF01706354 ID - Triginer1990 ER - TY - JOUR AU - Muller, M. AU - Haag, O. AU - Burgdorff, T. AU - Georgopoulos, A. AU - Weninger, W. AU - Jansen, B. AU - Stanek, G. AU - Pehamberger, H. AU - Agneter, E. AU - Eichler, H. G. PY - 1996 DA - 1996// TI - Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans JO - Antimicrob Agents Chemother VL - 40 ID - Muller1996 ER - TY - CHAP AU - Martin, J. H. AU - Fay, M. F. AU - Udy, A. AU - Roberts, J. AU - Kirkpatrick, C. AU - Ungerer, J. AU - Lipman, J. PY - 2010 DA - 2010// TI - Pitfalls of using estimations of glomerular filtration rate in an intensive care population BT - Intern Med J ID - Martin2010 ER -